Indraprastha Medical Corporation Limited (INDRAMEDCO.BO)

INR 499.25

(-0.7%)

Market Cap (In INR)

45.76 Billion

Revenue (In INR)

12.44 Billion

Net Income (In INR)

1.23 Billion

Avg. Volume

66.11 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
155.55-529.65
PE
-
EPS
-
Beta Value
0.814
ISIN
INE681B01017
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Shivakumar Pattabhiraman ACA, B Com, CWA, Grad.
Employee Count
-
Website
https://www.delhi.apollohospitals.com
Ipo Date
2001-07-05
Details
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, endovascular surgery, endocrinology, ENT, fetal medicine, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, ophthalmology, pediatric sciences, urology, and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neurology/neurosurgery, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, sleep medicine and clinical care, and transfusion medicine. The company was founded in 1983 and is based in New Delhi, India.